2018-2023 Global Breast Cancer Monoclonal Antibodies Market Report (Status and Outlook)

Publisher Name :
Date: 10-Sep-2018
No. of pages: 155

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Breast Cancer Monoclonal Antibodies market for 2018-2023.

Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protein stimulates the growth and division of malignant cells.

The breast cancer monoclonal antibodies (mAbs) market is one of the fastest-growing segments of the global mAbs market and has gained major research significance among biotech and pharmaceutical companies due to the presence of high unmet needs in this area. Antibodies are increasingly becoming the best choice to treat cancers, including breast cancer. The use of antibody-drug conjugates (ADCs),including radioimmunotherapy and antibody-directed enzyme prodrug therapy, is increasing rapidly. ADCs are highly effective cytotoxic drugs linked to mAbs. These drugs have shown to be potent and efficient in treating breast cancer. This has propelled vendors to focus on novel technologies such as Seattle Genetics (SGEN), ImmunoGen (IMGN), and Immunomedics (IMMU). The rising use of these antibodies in drug development increases revenue generation in the breast cancer mAbs market, contributing to market growth.

The breast cancer mAbs market in APAC will witness a high growth rate during the forecast period due to the better market penetration of breast cancer mAbs and biosimilars in emerging economies, especially in Japan, Australia, India, South Korea, and China. The rising number of initiatives undertaken by major vendors to assist patients in these countries is a significant contributor to the rise in sales of breast cancer mAbs in these countries. Moreover, the growing awareness about breast cancer and the available treatment alternatives will also propel growth prospects for the market growth in APAC.

Over the next five years, LPI(LP Information) projects that Breast Cancer Monoclonal Antibodies will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Breast Cancer Monoclonal Antibodies market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

- Naked MAbs

- Conjugated MAbs

Segmentation by application:

- Hospitals

- Retail Pharmacies

- Others

We can also provide the customized separate regional or country-level reports, for the following regions:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

- Amgen

- Roche

- Mylan

- Array BioPharma

- Biocad

- Boehringer Ingelheim

- Bristol-Myers Squibb

- Celldex Therapeutics

- Celltrion

- Daiichi Sankyo

- GlaxoSmithKline

- Immunomedics

- MacroGenics

- Merck

- Novartis

- Oncothyreon

- Pfizer

- Puma Biotechnology

- Seattle Genetics

- Sun Pharmaceutical Industries

- Synta Pharmaceuticals

- Teva Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Breast Cancer Monoclonal Antibodies market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Breast Cancer Monoclonal Antibodies market by identifying its various subsegments.

- Focuses on the key global Breast Cancer Monoclonal Antibodies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Breast Cancer Monoclonal Antibodies with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Breast Cancer Monoclonal Antibodies submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Breast Cancer Monoclonal Antibodies Market Report (Status and Outlook)

Table of Contents

2018-2023 Global Breast Cancer Monoclonal Antibodies Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Breast Cancer Monoclonal Antibodies Market Size 2013-2023
2.1.2 Breast Cancer Monoclonal Antibodies Market Size CAGR by Region
2.2 Breast Cancer Monoclonal Antibodies Segment by Type
2.2.1 Naked MAbs
2.2.2 Conjugated MAbs
2.3 Breast Cancer Monoclonal Antibodies Market Size by Type
2.3.1 Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
2.3.2 Global Breast Cancer Monoclonal Antibodies Market Size Growth Rate by Type (2013-2018)
2.4 Breast Cancer Monoclonal Antibodies Segment by Application
2.4.1 Hospitals
2.4.2 Retail Pharmacies
2.4.3 Others
2.5 Breast Cancer Monoclonal Antibodies Market Size by Application
2.5.1 Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
2.5.2 Global Breast Cancer Monoclonal Antibodies Market Size Growth Rate by Application (2013-2018)

3 Global Breast Cancer Monoclonal Antibodies by Players
3.1 Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Players
3.1.1 Global Breast Cancer Monoclonal Antibodies Market Size by Players (2016-2018)
3.1.2 Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Players (2016-2018)
3.2 Global Breast Cancer Monoclonal Antibodies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Breast Cancer Monoclonal Antibodies by Regions
4.1 Breast Cancer Monoclonal Antibodies Market Size by Regions
4.2 Americas Breast Cancer Monoclonal Antibodies Market Size Growth
4.3 APAC Breast Cancer Monoclonal Antibodies Market Size Growth
4.4 Europe Breast Cancer Monoclonal Antibodies Market Size Growth
4.5 Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Growth

5 Americas
5.1 Americas Breast Cancer Monoclonal Antibodies Market Size by Countries
5.2 Americas Breast Cancer Monoclonal Antibodies Market Size by Type
5.3 Americas Breast Cancer Monoclonal Antibodies Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Breast Cancer Monoclonal Antibodies Market Size by Countries
6.2 APAC Breast Cancer Monoclonal Antibodies Market Size by Type
6.3 APAC Breast Cancer Monoclonal Antibodies Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Breast Cancer Monoclonal Antibodies by Countries
7.2 Europe Breast Cancer Monoclonal Antibodies Market Size by Type
7.3 Europe Breast Cancer Monoclonal Antibodies Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Breast Cancer Monoclonal Antibodies by Countries
8.2 Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size by Type
8.3 Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Breast Cancer Monoclonal Antibodies Market Forecast
10.1 Global Breast Cancer Monoclonal Antibodies Market Size Forecast (2018-2023)
10.2 Global Breast Cancer Monoclonal Antibodies Forecast by Regions
10.2.1 Global Breast Cancer Monoclonal Antibodies Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Breast Cancer Monoclonal Antibodies Forecast by Type
10.8 Global Breast Cancer Monoclonal Antibodies Forecast by Application

11 Key Players Analysis
11.1 Amgen
11.1.1 Company Details
11.1.2 Breast Cancer Monoclonal Antibodies Product Offered
11.1.3 Amgen Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Amgen News
11.2 Roche
11.2.1 Company Details
11.2.2 Breast Cancer Monoclonal Antibodies Product Offered
11.2.3 Roche Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Roche News
11.3 Mylan
11.3.1 Company Details
11.3.2 Breast Cancer Monoclonal Antibodies Product Offered
11.3.3 Mylan Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Mylan News
11.4 Array BioPharma
11.4.1 Company Details
11.4.2 Breast Cancer Monoclonal Antibodies Product Offered
11.4.3 Array BioPharma Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Array BioPharma News
11.5 Biocad
11.5.1 Company Details
11.5.2 Breast Cancer Monoclonal Antibodies Product Offered
11.5.3 Biocad Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Biocad News
11.6 Boehringer Ingelheim
11.6.1 Company Details
11.6.2 Breast Cancer Monoclonal Antibodies Product Offered
11.6.3 Boehringer Ingelheim Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Boehringer Ingelheim News
11.7 Bristol-Myers Squibb
11.7.1 Company Details
11.7.2 Breast Cancer Monoclonal Antibodies Product Offered
11.7.3 Bristol-Myers Squibb Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Bristol-Myers Squibb News
11.8 Celldex Therapeutics
11.8.1 Company Details
11.8.2 Breast Cancer Monoclonal Antibodies Product Offered
11.8.3 Celldex Therapeutics Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Celldex Therapeutics News
11.9 Celltrion
11.9.1 Company Details
11.9.2 Breast Cancer Monoclonal Antibodies Product Offered
11.9.3 Celltrion Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Celltrion News
11.10 Daiichi Sankyo
11.10.1 Company Details
11.10.2 Breast Cancer Monoclonal Antibodies Product Offered
11.10.3 Daiichi Sankyo Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 Daiichi Sankyo News
11.11 GlaxoSmithKline
11.12 Immunomedics
11.13 MacroGenics
11.14 Merck
11.15 Novartis
11.16 Oncothyreon
11.17 Pfizer
11.18 Puma Biotechnology
11.19 Seattle Genetics
11.20 Sun Pharmaceutical Industries
11.21 Synta Pharmaceuticals
11.22 Teva Pharmaceuticals

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Breast Cancer Monoclonal Antibodies
Figure Breast Cancer Monoclonal Antibodies Report Years Considered
Figure Market Research Methodology
Figure Global Breast Cancer Monoclonal Antibodies Market Size Growth Rate 2013-2023 ($ Millions)
Table Breast Cancer Monoclonal Antibodies Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Naked MAbs
Table Major Players of Conjugated MAbs
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure Global Naked MAbs Market Size Growth Rate
Figure Global Conjugated MAbs Market Size Growth Rate
Figure Breast Cancer Monoclonal Antibodies Consumed in Hospitals
Figure Global Breast Cancer Monoclonal Antibodies Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Breast Cancer Monoclonal Antibodies Consumed in Retail Pharmacies
Figure Global Breast Cancer Monoclonal Antibodies Market: Retail Pharmacies (2013-2018) ($ Millions)
Figure Global Retail Pharmacies YoY Growth ($ Millions)
Figure Breast Cancer Monoclonal Antibodies Consumed in Others
Figure Global Breast Cancer Monoclonal Antibodies Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size by Application (2013-2018) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Market Size in Hospitals Growth Rate
Figure Global Breast Cancer Monoclonal Antibodies Market Size in Retail Pharmacies Growth Rate
Figure Global Breast Cancer Monoclonal Antibodies Market Size in Others Growth Rate
Table Global Breast Cancer Monoclonal Antibodies Revenue by Players (2016-2018) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Players (2016-2018)
Figure Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Players in 2017
Table Global Breast Cancer Monoclonal Antibodies Key Players Head office and Products Offered
Table Breast Cancer Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Breast Cancer Monoclonal Antibodies Market Size by Regions 2013-2018 ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Regions 2013-2018
Figure Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Regions 2013-2018
Figure Americas Breast Cancer Monoclonal Antibodies Market Size 2013-2018 ($ Millions)
Figure APAC Breast Cancer Monoclonal Antibodies Market Size 2013-2018 ($ Millions)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size 2013-2018 ($ Millions)
Table Americas Breast Cancer Monoclonal Antibodies Market Size by Countries (2013-2018) ($ Millions)
Table Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries (2013-2018)
Figure Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries in 2017
Table Americas Breast Cancer Monoclonal Antibodies Market Size by Type (2013-2018) ($ Millions)
Table Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Type in 2017
Table Americas Breast Cancer Monoclonal Antibodies Market Size by Application (2013-2018) ($ Millions)
Table Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Application in 2017
Figure United States Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Canada Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Table APAC Breast Cancer Monoclonal Antibodies Market Size by Countries (2013-2018) ($ Millions)
Table APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries (2013-2018)
Figure APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries in 2017
Table APAC Breast Cancer Monoclonal Antibodies Market Size by Type (2013-2018) ($ Millions)
Table APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Type in 2017
Table APAC Breast Cancer Monoclonal Antibodies Market Size by Application (2013-2018) ($ Millions)
Table APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Application in 2017
Figure China Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Japan Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Korea Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure India Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Australia Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Table Europe Breast Cancer Monoclonal Antibodies Market Size by Countries (2013-2018) ($ Millions)
Table Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries (2013-2018)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries in 2017
Table Europe Breast Cancer Monoclonal Antibodies Market Size by Type (2013-2018) ($ Millions)
Table Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Type in 2017
Table Europe Breast Cancer Monoclonal Antibodies Market Size by Application (2013-2018) ($ Millions)
Table Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Application in 2017
Figure Germany Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure France Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure UK Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Italy Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Russia Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Spain Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries in 2017
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Type in 2017
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Application in 2017
Figure Egypt Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Israel Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Global Breast Cancer Monoclonal Antibodies arket Size Forecast (2018-2023) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share Forecast by Regions
Figure Americas Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure APAC Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure United States Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Canada Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Mexico Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Brazil Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure China Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Japan Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Korea Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure India Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Australia Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Germany Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure France Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure UK Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Italy Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Russia Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Spain Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Egypt Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure South Africa Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Israel Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Turkey Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure GCC Countries Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share Forecast by Type (2018-2023)
Table Global Breast Cancer Monoclonal Antibodies Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share Forecast by Application (2018-2023)
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Amgen Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Roche Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Mylan Basic Information, Head Office, Major Market Areas and Its Competitors
Table Mylan Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Mylan Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Array BioPharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Array BioPharma Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Array BioPharma Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Biocad Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biocad Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Biocad Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Head Office, Major Market Areas and Its Competitors
Table Boehringer Ingelheim Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Boehringer Ingelheim Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Celldex Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celldex Therapeutics Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Celldex Therapeutics Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Celltrion Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celltrion Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Celltrion Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Daiichi Sankyo Basic Information, Head Office, Major Market Areas and Its Competitors
Table Daiichi Sankyo Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Daiichi Sankyo Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Head Office, Major Market Areas and Its Competitors
Table Immunomedics Basic Information, Head Office, Major Market Areas and Its Competitors
Table MacroGenics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Oncothyreon Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Puma Biotechnology Basic Information, Head Office, Major Market Areas and Its Competitors
Table Seattle Genetics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sun Pharmaceutical Industries Basic Information, Head Office, Major Market Areas and Its Competitors
Table Synta Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
  • Global Small Cell Lung Cancer Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 137
    Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell carcinoma. It can be further classified into two stages: limited-stage small cell lung cancer and extensive-stage small cell lung cancer. Small cell lung cancer is caused by smoking tobacco, or second ha......
  • Global Ovarian Cancer Therapeutics Market Size, Status and Forecast 2018-2025
    Published: 17-Sep-2018        Price: US 3900 Onwards        Pages: 98
    This report focuses on the global Ovarian Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ovarian Cancer Therapeutics development in United States, Europe and China. Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and ......
  • Global Non-Melanoma Skin Cancer Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 17-Sep-2018        Price: US 3480 Onwards        Pages: 139
    Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Scope of the Report: This report studies the Non-Melanoma Skin Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-Melanoma Skin Cancer market by p......
  • Global Non-Melanoma Skin Cancer Market Size, Status and Forecast 2018-2025
    Published: 12-Sep-2018        Price: US 3900 Onwards        Pages: 108
    This report focuses on the global Non-Melanoma Skin Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Melanoma Skin Cancer development in United States, Europe and China. Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non......
  • 2018-2023 Global Bladder Cancer Therapeutics Market Report (Status and Outlook)
    Published: 10-Sep-2018        Price: US 4660 Onwards        Pages: 119
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Bladder Cancer Therapeutics market for 2018-2023. The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the innermost lay......
  • Global Circulating Tumor Cells Market by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 10-Sep-2018        Price: US 3480 Onwards        Pages: 152
    Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy. Scope of the Report: This report studies the Circulating Tumor Cells market status and outlook of Global and major regions, from angles of playe......
  • Global Melanoma Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Melanoma Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and ......
  • Global Multiple Myeloma Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Multiple Myeloma Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understand......
  • Global Ovarian Cancer Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." The Global Ovarian Cancer Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understandin......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs